3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
This substance is on the EU list of fragrance allergens that must be named individually in the ingredient list, rather than being covered by the word "parfum", once it exceeds 0.001% in a leave-on product or 0.01% in a rinse-off product.
This substance is also prohibited in EU cosmetics, so the declaration applies only to an unintended trace that Article 17 tolerates — not to anything deliberately added. See the allergen record
Chemical identity and properties

Liral
- IUPAC name
- 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
- Molecular formula
- C13H22O2
- Molecular weight
- 210.31 g/mol
- Exact mass
- 210.161979940 Da
- XLogP3
- 1.7
- Topological polar surface area
- 37.3 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

3-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
- IUPAC name
- 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
- Molecular formula
- C13H22O2
- Molecular weight
- 210.31 g/mol
- Exact mass
- 210.161979940 Da
- XLogP3
- 1.7
- Topological polar surface area
- 37.3 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
External database identifiers
- EPA DTXSID:DTXSID2052152
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
Chemical / IUPAC name
3- and 4-(4-Hydroxy-4-methylpentyl) cyclohex-3-ene-1-carbaldehyde (HICC)
Regulatory information
SCCS opinions
- Opinion on Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral)
- Opinion on Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral)
- Opinion concerning Essential Oils
- Opinion concerning Fragrance Allergy in Consumers - A Review of the Problem - Analysis of the need for appropriate Consumer Information and Identification of Consumer Allergens
- Opinion concerning the Interim Position on Fragrance Allergy
- Memorandum on the SCCNFP Opinion concerning Fragrance Allergy
Identified ingredients
EU Fragrance Allergen
This substance is linked to an EU fragrance-allergen reference. Check the current Annex III entry for the declaration threshold and any additional conditions.
Key data
Inventory links for 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
HYDROXYISOHEXYL 3-CYCLOHEXENE CARBOXALDEHYDE
Related records for 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
2,6-Dihydroxy-4-methyl-benzaldehyde (atranol)
Pentyl 4-hydroxybenzoate (INCI: Pentylparaben)
3-Chloro-2,6-Dihydroxy-4-methyl-benzaldehyde (chloroatranol)(*)
Benzyl 4-hydroxybenzoate (INCI: Benzylparaben)
Tagetes erecta flower extract, Tagetes erecta flower oil
Phenyl 4-hydroxybenzoate (INCI: Phenylparaben)
2-chlorobenzene-1,4-diamine (2-Chloro-p-Phenylenediamine), its sulfate and dihydrochloride salts wh…
Isobutyl 4-hydroxybenzoate (INCI: Isobutylparaben) /Sodium salt or Salts of Isobutylparaben
Cis-1-(3-chloroallyl)-3,5,7- triaza-1-azoniaadamantane chloride (cis-CTAC)
Isopropyl 4-hydroxybenzoate (INCI: Isopropylparaben) Sodium salt or Sats of Isopropylparaben
Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC), quaternium-15
What Annex II means for 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
This record is linked to 1 CosIng inventory ingredient for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
- This substance is a regulated fragrance allergen. Declare it on the label by INCI name above 0.001% in leave-on or 0.01% in rinse-off products.
Frequently asked questions
Source note for Annex II record 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
This page summarizes one Annex II record for 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare 3 and 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II